Feasibility of monitoring advanced melanoma patients using cell‐free DNA from plasma

Summary To determine the feasibility of liquid biopsy for monitoring of patients with advanced melanoma, cell‐free DNA was extracted from plasma for 25 Stage III/IV patients, most (84.0%) having received previous therapy. DNA concentrations ranged from 0.6 to 390.0 ng/ml (median = 7.8 ng/ml) and wer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pigment cell and melanoma research Jg. 31; H. 1; S. 73 - 81
Hauptverfasser:	Gangadhar, Tara C., Savitch, Samantha L., Yee, Stephanie S., Xu, Wei, Huang, Alexander C., Harmon, Shannon, Lieberman, David B., Soucier, Devon, Fan, Ryan, Black, Taylor A., Morrissette, Jennifer J. D., Salathia, Neeraj, Waters, Jill, Zhang, Shile, Toung, Jonathan, Hummelen, Paul, Fan, Jian‐Bing, Xu, Xiaowei, Amaravadi, Ravi K., Schuchter, Lynn M., Karakousis, Giorgos C., Hwang, Wei‐Ting, Carpenter, Erica L.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Wiley Subscription Services, Inc 01.01.2018
Schlagworte:	Biomarkers, Tumor - blood Biomarkers, Tumor - genetics Biopsy Cell-Free Nucleic Acids - blood Cell-Free Nucleic Acids - genetics cell‐free circulating tumor DNA Correlation analysis Deoxyribonucleic acid DNA Feasibility Feasibility Studies Female Gene sequencing High-Throughput Nucleotide Sequencing Humans liquid biopsy Male Melanoma Melanoma - blood Melanoma - diagnosis Melanoma - genetics Middle Aged Monitoring Mutation Patients Pilot Projects precision medicine Skin Neoplasms - blood Skin Neoplasms - diagnosis Skin Neoplasms - genetics Therapy melanoma precision medicine cell-free circulating tumor DNA liquid biopsy
ISSN:	1755-1471, 1755-148X, 1755-148X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!